Scholars Central

Conference abstractPublished 8 Jun 2015

Regulation of Raf kinase as predictor for therapeutic effects

Authors: Karin Moelling

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The Raf kinase was discovered 30 years ago as a retroviral oncogen. It is activated in several human cancers and a major target of recent drug therapy. However, the Raf kinase can also induce differentiation instead of proliferation, depending on the cell-type and growth factor stimuli. We described a cross-talk between the Raf-kinase and the PI3Kinase pathways which influences the cellular responses. Thus, in cells where the Raf kinase is normally inducing differentiation, anti-cancer drugs may induce prolieration and cause an undesired opposite effect. This has been observed repeatedly in patients treated with one of the novel drugs against the Raf kinase. We also described previously two negative feedback loops inducing upstream signalling from Raf-MEK to the EGF receptor. Again, inhibition of this loop by drugs against Raf may induce the opposite effect. This was indeed observed in patients and therefore recently a dual therapy was applied in order to compensate for the loss of the negative feedback, with some therapeutic success. Considering the unexpected counterintuitive effects of Raf kinase inhibitors and novel therapeutics it is worth discussing the known regulatory mechanisms we have described, and avoid side-effects.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Virology & Mycology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalVirology & Mycology
  • SubjectInfectious Diseases
  • SubjectMicrobiology
  • BylineArticles whose byline prints “Karin Moelling”